Why is fair value unavailable for Decision Diagnostics (OTC-DECN) stock?

A reliable fair value estimate is not currently available for Decision Diagnostics (OTC-DECN). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

How is the financial health of Decision Diagnostics?

The current financial health read for Decision Diagnostics (OTC-DECN) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Decision Diagnostics (OTC-DECN) pay dividends?

The latest available data indicates no current dividend yield for Decision Diagnostics (OTC-DECN).

What is the market capitalization of Decision Diagnostics?

The current market capitalization listed for Decision Diagnostics is 0.38 K.

What is the ticker symbol for Decision Diagnostics?

The ticker symbol for Decision Diagnostics is OTC-DECN, and the stock is listed on OTC Markets.

Where is Decision Diagnostics (OTC-DECN) listed?

Decision Diagnostics (OTC-DECN) is listed on OTC Markets.

Decision Diagnostics (DECN) Fair Value & Stock Analysis

Decision Diagnostics (DECN)

Decision Diagnostics Corp. is a healthcare technology company listed on OTC Markets as common stock. The company develops smartphone-based electronic medical record, or EMR, technologies and related e-health software for use at the point of care. Its business includes prescription and non-prescription diagnostics, home testing products for people with chronic illness, and direct-to-patient diabetes program fulfillment services. Decision Diagnostics also manufactures and distributes a range of glucose-testing products, including GenUltimate! glucose test strips for at-home use, PetSure! strips for veterinary testing, and the GenUltimate! 4Pets glucose system for dogs, cats, and horses. In addition, it offers software products such as MD@Hand, Practice Probe, and ResidenceWare, while also holding intellectual property and specialty manufacturing equipment. The company was founded in 2000 and is based in Westlake Village, California.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-DECN	Not available	Not available	Not available	Weak	0.0%	0.38 K